Data powered by Alphabet Inc.
Eris Lifesciences
ERIS
₹ 1,435.16
- ₹ 13.29
-0.91%
Eris Lifesciences Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | -0.91% | 3,18,175 |
| Weekly | 1.82% | 7,92,299 |
| Monthly | 19.72% | 43,65,843 |
Eris Lifesciences Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| ERIS | -0.91% | 1.82% | 19.72% |
| Index | - | - | - |
| Peer Avg. | 1.14% | 4.06% | 11.33% |
*Avg of index constituents
Eris Lifesciences Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| ERIS | 22.76 | 4.90 | 17.02 | 23.62 | 25.86 | 0.94 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
*Avg of index constituents
Eris Lifesciences Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 10.40% | 16.63% | 23.62% | 25.86% |
| FY '20-21 | 10.76% | 20.07% | 24.61% | 27.36% |
| FY '19-20 | 11.58% | 1.95% | 24.02% | 25.09% |
Eris Lifesciences Shareholding Pattern
Promoters : 52.66%
FII : 13.31%
DII : 10.5%
Public : 23.52%
Others : 0.01%
Eris Lifesciences Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 1,281.39 | 796.85 | 512.08 | 411.49 |
| FY '20-21 | 1,160.35 | 736.24 | 433.46 | 352.87 |
| FY '19-20 | 1,047.14 | 685.72 | 377.17 | 293.89 |
All values are in crores
Eris Lifesciences Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| ERIS | 1,281.39 | 796.85 | 512.08 | 411.49 |
| GRANULES | 3,501.68 | 2,818.85 | 701 | 399.64 |
| NATCOPHARM | 1,856.30 | 1,618.05 | 335.05 | 154.55 |
All values are in crores
Eris Lifesciences Share Price
Eris Lifesciences Limited is an Indian company primarily engaged in the production and distribution of pharmaceutical products. The company's manufacturing facility is located in Guwahati, Assam. Its therapeutic areas include oral diabetes, cardiac, pain/analgesic, gynecology, gastrointestinal, central nervous system (CNS) and vitamins, minerals and nutrients (VMN). The company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cybex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The company's 100% subsidiaries are Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.
Eris Lifesciences FAQs
How to Buy Eris Lifesciences Share?
To purchase Eris Lifesciences shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Eris Lifesciences (ticker symbol: ERIS) on the trading platform provided by your broker and purchase the shares.
What's Eris Lifesciences share price today?
The stock price of Eris Lifesciences as of 09 Sep 2024 is ₹1,435.16
What is the Market Cap of Eris Lifesciences?
Market capitalisation represents the total market value of a company's outstanding shares. As of 09 Sep 2024, Eris Lifesciences (ticker symbol: ERIS) has a market capitalisation of approximately ₹87,13,60,51,917.75
What is the PE and PB ratio of Eris Lifesciences?
Eris Lifesciences Ltd's price-to-book ratio as of 09 Sep 2024 is 4.9002485, reflecting the market's valuation compared to its asset value. As of 09 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 22.758598, indicating the market values the company at around ₹22.76 for every ₹1 of earnings
What is the 52 Week High and Low of Eris Lifesciences Share?
Eris Lifesciences Ltd (ERIS) hit its 52-week high at ₹1,521.89, and its 52-week low at { ₹551.50}.